Other
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Thermo Fisher Scientific Cash Provided by (Used in) Financing Activity, Including Discontinued Operation increased by 1171.6% to $1.09B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1171.6%, from -$102.00M to $1.09B.
Analysis
StatementIncome Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ1 2017
Last reportedQ1 2026May 1, 2026
How to read this metric
Negative values often indicate significant share buybacks or debt repayment, while positive values suggest new capital raising or increased borrowing.
Detailed definition
The total net cash flow resulting from all financing activities, including proceeds from debt issuance, share repurchase...
Peer comparison
Standard line item in the Statement of Cash Flows for all public companies.
Metric ID:
other_net_cash_provided_by_used_in_financing_activitiesHistorical Data
13 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$76.00M | $3.04B | -$3.15B | -$1.91B | -$151.00M | -$2.59B | -$1.46B | $1.86B | -$1.82B | -$115.00M | -$1.19B | -$102.00M | $1.09B |
| QoQ Change | — | >999% | -203.5% | +39.4% | +92.1% | <-999% | +43.8% | +227.4% | -198.2% | +93.7% | -934.8% | +91.4% | >999% |
| YoY Change | — | — | — | <-999% | -105.0% | +17.6% | +23.6% | >999% | +29.8% | +92.1% | -164.2% | +94.4% | >999% |
Range-$3.15B – $3.04B
CAGR+143.2%
Avg YoY Growth+8.2%
Median YoY Growth+26.7%
Current Streak2 quarters growth
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's cash provided by (used in) financing activity, including discontinued operation?
- Thermo Fisher Scientific (TMO) reported cash provided by (used in) financing activity, including discontinued operation of $1.09B in Q1 2026.
- How has Thermo Fisher Scientific's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
- Thermo Fisher Scientific's cash provided by (used in) financing activity, including discontinued operation increased by 1171.6% year-over-year, from -$102.00M to $1.09B.
- What does cash provided by (used in) financing activity, including discontinued operation mean?
- The net change in cash resulting from all financing-related activities.